According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -1,17ย โฌ. In 2022 the company made an earnings per share (EPS) of -1,24ย โฌ a decrease over its 2021 EPS that were of -0,96ย โฌ.